US2018180589A1PendingUtilityA1
Point of care sepsis assay device and method
Est. expiryDec 20, 2032(~6.4 yrs left)· nominal 20-yr term from priority
Inventors:Anthony Nicholls
G01N 33/49G01N 33/491G01N 15/06G01N 2015/0687G01N 21/59
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed is a point of care sepsis assay comprising a disposable assay cartridge with a sample inlet for a blood sample, a filter to isolate blood plasma, a source of multivalent cations to cause a turbidity change in the plasma sample and a transparent window to measure the change in turbidity and the use of said assay in the diagnosis of sepsis.
Claims
exact text as granted — not AI-modified1 - 21 . (canceled)
22 . An assay cartridge device for detecting sepsis in blood plasma comprising a reaction chamber with a dried material containing a source of multivalent cations, where the dried material is present only on a portion of the surface of the reaction chamber, the cations causing a turbidity change in the plasma sample in the presence of sepsis, and a transparent window to measure the change in turbidity.
23 . A device according to claim 22 wherein the device has an integral filter to isolate blood plasma from a blood sample.
24 . A device according to claim 23 wherein the device is a disposable, single use device.
25 . A device according to claim 22 wherein the multivalent cation is a divalent cation.
26 . A device according to claim 25 wherein the divalent cations are metal ions.
27 . A device according to claim 26 wherein the metal is calcium.
28 . A device according to claim 22 wherein the device comprises a reaction chamber of defined volume wherein the volume of the reaction chamber is 10-50 microlitres (μL).
29 . A device according to claim 22 wherein the window is transparent at 480 nm.
30 . A device according to claim 22 wherein the optical path length of the transparent window is 0.5 mm to 10 mm.
31 . A device according to claim 30 wherein the optical path length of the transparent window is 0.5 mm to 2 mm.
32 . A device according to claim 25 wherein the divalent cations are present at a final concentration of greater than 10 mM in the first reaction chamber when the blood plasma has been added.
33 . A device according to claim 22 wherein the cations are dried in a layer of water soluble polymer.
34 . A device according to claim 33 wherein the polymer is polyethylene glycol or methyl polyethylene glycol.
35 . A device according to claim 22 further comprising a reader instrument comprising a source of visible light.
36 . A device according to claim 35 wherein the reader instrument comprises a measuring element for detecting the amount of light passing through the sample.
37 . A device according to claim 36 wherein the measuring element is a photodiode.
38 . A device according to claim 36 wherein the reader instrument comprises a pinhole between the measuring element and the sample.Join the waitlist — get patent alerts
Track US2018180589A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.